Subtype
Skin Squamous Cell Carcinoma
CI-CAN-00003959Explore in graph →
89 active trials1 approved drugs3 evidence items
- NCIt
- C4819
- OncoTree
- CSCC
- DOID
- 3151
- UMLS CUI
- C0553723
- MeSH
- D000099314
Loading cancer entity…
Subtype
CI-CAN-00003959Explore in graph →
Clinical trials
211 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (39)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04670445 | Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer(UPLIFT) | completed | N/A | 199 | Massachusetts General HospitalOTHER | 1 | Aug 25, 2026 | clinicaltrials |
| NCT04389112 | Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions(MITOSKIN) | completed | N/A | 119 | University Hospital, BordeauxOTHER | 1 | Jun 24, 2026 |
| clinicaltrials |
| NCT02324608 | Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer | completed | N/A | 15 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT03353077 | Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT) | completed | N/A | 28 | Alpha Tau Medical LTD.INDUSTRY | 1 | Mar 10, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Aug 25, 2026source: clinicaltrials